Reduced CXCR4-expression on CD34-positive blood cells predicts outcomes of persons with primary myelofibrosis.

Leukemia
Giovanni BarosiRita Campanelli

Abstract

The expression of the CXCR4 chemokine receptor on CD34-positive blood cells is reduced in persons with primary myelofibrosis (PMF). We analyzed the relevance of cytofluorimetric assessment of the percentage of CD34-positive blood cells that had a positive CXCR4 surface expression (CD34/CXCR4-se) in a large cohort of subjects with myeloproliferative neoplasms. Mean CD34/CXCR4-se was lower in subjects with PMF compared with those with essential thrombocythemia (ET) or polycythemia vera (PV). A cutoff value of 39% was associated with a diagnosis of pre-fibrotic PMF vs. ET with a positive predictive value of 97%. In PMF male sex, older age, and MPL mutation were independent correlates of reduced CD34/CXCR4-se and associated with a briefer interval to development of severe anemia, large splenomegaly, thrombocytopenia, leukopenia, elevated CD34-positive blood cells, blast transformation and death. We constructed a prognostic model including age >65 years, hemoglobin < 100 g/L, CD34-positive blood cells > 50 × 106/L, and CD34/CXCR4-se <39% at diagnosis. The model identified three risk cohorts with greater accuracy compared with the International Prognostic Scoring System. In conclusion, CD34/CXCR4-se is a highly sensitive marker of di...Continue Reading

References

Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·Q MaT A Springer
Mar 14, 2007·Blood Cells, Molecules & Diseases·Vittorio RostiUNKNOWN Myeloproliferative Disorders Research Consortium
Apr 6, 2007·British Journal of Haematology·Paola GuglielmelliUNKNOWN MPD Research Consortium
May 31, 2008·Stem Cells·Costanza BoganiUNKNOWN Myeloproliferative Disorders Research Consortium
Aug 6, 2010·Leukemia Research·R A MesaR P Gale
Jun 4, 2016·Applied Immunohistochemistry & Molecular Morphology : AIMM·Hany SakrJames R Cook
Jun 10, 2016·Cell Death & Disease·E Panieri, M M Santoro
Oct 12, 2018·The New England Journal of Medicine·Jacob GrinfeldPeter J Campbell

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

STATISTICA

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

Current Opinion in Oncology
Francisco Cervantes, Arturo Pereira
The Korean Journal of Internal Medicine
Katsuto TakenakaKoichi Akashi
Schweizerische medizinische Wochenschrift
A TichelliE Signer
© 2022 Meta ULC. All rights reserved